Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raluca I Mincu

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
ESC Heart Failure|July 13, 2019
Heart failure from cancer therapy: can we prevent it?Matthias Totzeck, Raluca I Mincu, Gerd Heusch, et al.
Pneumologia (Bucharest, Romania)|July 26, 2016
The efficiency of continuous positive airway pressure therapy in reducing cardiovascular dysfunction in a patient with arterial hypertension and obstructive sleep apneaStefania L Magda, Raluca I Mincu, Stefan Dumitrache-Rujinski, et al.
Current Heart Failure Reports|February 19, 2025
Prevention of cancer-therapy related cardiac dysfunctionElias Haj-Yehia, Lars Michel, Raluca I Mincu, et al.
Maedica|March 7, 2017
Atherosclerosis in Systemic Sclerosis: a Modern ControversyStefania L Magda, Raluca I Mincu, Carmen M Mihai, et al.
Journal of Clinical Medicine|September 10, 2021
Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease-A Meta-AnalysisRaluca I Mincu, Lena F Lampe, Amir A Mahabadi, et al.
ESC Heart Failure|February 19, 2020
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysisLars Michel, Raluca I Mincu, Simone M Mrotzek, et al.
British Journal of Pharmacology|March 11, 2026
Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio-oncology RegistryElias Haj-Yehia, Lisa Zimmer, Lena Lampe, et al.
JAMA Network Open|August 10, 2019
Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysisRaluca I Mincu, Amir A Mahabadi, Lars Michel, et al.
British Journal of Pharmacology|May 14, 2026
Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuumFabrice Reyes, Florian Buehning, Tobias Lerchner, et al.
European Journal of Heart Failure|November 14, 2019
Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysisLars Michel, Raluca I Mincu, Amir A Mahabadi, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
ESC Heart Failure|July 13, 2019
Heart failure from cancer therapy: can we prevent it?Matthias Totzeck, Raluca I Mincu, Gerd Heusch, et al.
Pneumologia (Bucharest, Romania)|July 26, 2016
The efficiency of continuous positive airway pressure therapy in reducing cardiovascular dysfunction in a patient with arterial hypertension and obstructive sleep apneaStefania L Magda, Raluca I Mincu, Stefan Dumitrache-Rujinski, et al.
Current Heart Failure Reports|February 19, 2025
Prevention of cancer-therapy related cardiac dysfunctionElias Haj-Yehia, Lars Michel, Raluca I Mincu, et al.
Maedica|March 7, 2017
Atherosclerosis in Systemic Sclerosis: a Modern ControversyStefania L Magda, Raluca I Mincu, Carmen M Mihai, et al.
Journal of Clinical Medicine|September 10, 2021
Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease-A Meta-AnalysisRaluca I Mincu, Lena F Lampe, Amir A Mahabadi, et al.
ESC Heart Failure|February 19, 2020
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysisLars Michel, Raluca I Mincu, Simone M Mrotzek, et al.
British Journal of Pharmacology|March 11, 2026
Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio-oncology RegistryElias Haj-Yehia, Lisa Zimmer, Lena Lampe, et al.
JAMA Network Open|August 10, 2019
Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysisRaluca I Mincu, Amir A Mahabadi, Lars Michel, et al.
British Journal of Pharmacology|May 14, 2026
Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuumFabrice Reyes, Florian Buehning, Tobias Lerchner, et al.
European Journal of Heart Failure|November 14, 2019
Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysisLars Michel, Raluca I Mincu, Amir A Mahabadi, et al.
Pageof 3